UM
New targets and inhibitors of HBV replication to combat drug resistance
Cheng Y.-C.1; Ying C.-X.1; Leung C.-H.1; Li Y.1
2005-12-01
Source PublicationJournal of Clinical Virology
ISSN13866532
Volume34Issue:SUPPL. 1
AbstractAll the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replication was discovered. A brief description of their mode of action is given. © 2005 Elsevier B.V. All rights reserved.
KeywordHBV replication Helioxanthin Nucleos(t)ide analogues
DOI10.1016/S1386-6532(05)80026-5
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:24   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Yale University School of Medicine
2.Huashan Hospital
Recommended Citation
GB/T 7714
Cheng Y.-C.,Ying C.-X.,Leung C.-H.,et al. New targets and inhibitors of HBV replication to combat drug resistance[J]. Journal of Clinical Virology,2005,34(SUPPL. 1).
APA Cheng Y.-C.,Ying C.-X.,Leung C.-H.,&Li Y..(2005).New targets and inhibitors of HBV replication to combat drug resistance.Journal of Clinical Virology,34(SUPPL. 1).
MLA Cheng Y.-C.,et al."New targets and inhibitors of HBV replication to combat drug resistance".Journal of Clinical Virology 34.SUPPL. 1(2005).
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Cheng Y.-C.]'s Articles
[Ying C.-X.]'s Articles
[Leung C.-H.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Cheng Y.-C.]'s Articles
[Ying C.-X.]'s Articles
[Leung C.-H.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Cheng Y.-C.]'s Articles
[Ying C.-X.]'s Articles
[Leung C.-H.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.